News & Perspective

Feb 04, 2004

Feb 04, 2004

USDA review panel urges tightening BSE rules

(CIDRAP News) – A panel of experts that reviewed the US response to the nation's first case of bovine spongiform encephalopathy (BSE) says there are probably other cases in the United States and recommends increasing restrictions designed to keep BSE-infected materials out of human food and animal feed.

Feb 16, 2004

Feb 16, 2004

Member of BSE review panel sees no clash with Harvard study

(CIDRAP News) – The recent prediction from a panel of experts that the United States is likely to see more cases of bovine spongiform encephalopathy (BSE) does not clash with a previous Harvard University study that described a low risk of the disease, according to a member of the panel.

Feb 09, 2005

Feb 09, 2005

FDA panel favors new BSE-related rule on blood donations

(CIDRAP News) – To help prevent the spread of variant Creutzfeldt-Jakob disease (vCJD) in the United States, a federal advisory committee recommended yesterday that anyone who received a blood transfusion in France after 1980 should not be allowed to give blood.

Aug 24, 2005

Aug 24, 2005

Roche to give flu drug to WHO to fight pandemic

(CIDRAP News) – The Swiss drug company Roche has pledged to give the World Health Organization (WHO) enough doses of the antiviral drug oseltamivir (Tamiflu) to treat 3 million people, in the hope that it could help to stave off or delay an influenza pandemic.

Apr 11, 2006

Apr 11, 2006

Avian flu in Myanmar concerns FAO

(CIDRAP News) – Avian influenza is continuing its spread among birds in many countries worldwide, with widespread outbreaks reported in Myanmar.

More than 100 outbreaks have occurred in poultry in Myanmar (formerly Burma) since the presence of H5N1 avian flu was announced there about a month ago, officials from the United Nations Food and Agriculture Organization (FAO) told Reuters news service yesterday.

Aug 16, 2007

Aug 16, 2007

Glaxo sells more H5N1 vaccine to US, launches trial

(CIDRAP News) – The British pharmaceutical company GlaxoSmithKline (GSK) recently announced another major order of prepandemic H5N1 influenza vaccine from the US Department of Health and Human Services (HHS), along with plans to launch a North American clinical trial of the vaccine.

Oct 26, 2007

Oct 26, 2007

THE PANDEMIC VACCINE PUZZLE Part 2: Vaccine production capacity falls far short

Editor's note: This is the second in a seven-part series investigating the prospects for development of vaccines to head off the threat of an influenza pandemic posed by the H5N1 avian influenza virus. The series puts promising advances in vaccine technology in perspective by illuminating the formidable barriers to producing large amounts of an effective and widely usable vaccine in a short time frame.

Nov 15, 2007

Nov 15, 2007

THE PANDEMIC VACCINE PUZZLE Can we vaccinate enough people in time to matter?

Maryn McKennaContributing Writer

(CIDRAP News) – This in-depth article investigates the prospects for development of vaccines to head off the threat of an influenza pandemic posed by the H5N1 avian influenza virus. Its seven parts put advances in vaccine technology in perspective by illuminating the formidable barriers to producing an effective and widely usable vaccine in a short time frame.

May 01, 2009

May 01, 2009

SWINE FLU BREAKING NEWS: Case counts, antiviral purchase, worried patients, Mexico timeline, 300 US schools close, Hong Kong quarantine

 

The World Health Organization (WHO) reported 331 cases of swine influenza H1N1 in 11 countries as of 6 a.m. GMT today. The case numbers by country are United States, 109 (1 death) (these are yesterday's totals); Mexico, 156 (9 deaths), Canada, 34; Spain, 13; United Kingdom, 8; New Zealand, 3; Germany, 3; Israel, 2; and 1 each in Austria, the Netherlands, and Switzerland. [WHO update 7]

Pages

by country

by organization

Newsletter Sign-up

Get CIDRAP news and other free newsletters.

Sign up now»

OUR UNDERWRITERS

Unrestricted financial support provided by

Bentson Foundation 3MAccelerate DiagnosticsGilead 
Grant support for ASP provided by


bioMérieux

  Become an underwriter»